Blend Labs Inc (NYSE:BLND)’s traded shares stood at 0.83 million during the latest session, with the company’s beta value hitting 1.34. At the last check today, the stock’s price was $5.47, to imply an increase of 6.63% or $0.34 in intraday trading. The BLND share’s 52-week high remains $5.40, putting it 1.28% up since that peak but still an impressive 72.39% since price per share fell to its 52-week low of $1.51. The company has a valuation of $1.40B, with an average of 3.54 million shares in intraday trading volume over the past 10 days and average of 2.48 million shares over the past 3 months.

Analysts have given a consensus recommendation of Buy for Blend Labs Inc (BLND), translating to a mean rating of 1.67. Of 3 analyst(s) looking at the stock, 0 analyst(s) give BLND a Sell rating. 0 of those analysts rate the stock as Overweight while 1 advise Hold as 2 recommend it as a Buy. 0 analyst(s) have given it an Underweight rating. Estimates put the company’s current-quarter earnings per share at 0.01.

Blend Labs Inc (NYSE:BLND) trade information

After registering a 6.63% upside in the latest session, Blend Labs Inc (BLND) has traded red over the past five days. The 5-day price performance for the stock is 7.05%, and 41.71% over 30 days. With these gigs, the year-to-date price performance is 114.51%. Short interest in Blend Labs Inc (NYSE:BLND) saw shorts transact 9.29 million shares and set a 4.28 days time to cover.

The extremes give us $4.75 and $4.75 for target low and target high price respectively. As such, BLND has been trading 13.16% off suggested target high and 13.16% from its likely low.

Blend Labs Inc (BLND) estimates and forecasts

Looking at statistics comparing Blend Labs Inc share performance against respective industry, we note that the company has outperformed competitors. Blend Labs Inc (BLND) shares are 105.64% up over the last 6 months, with its year-to-date growth rate higher than industry average at 82.50% against 24.60%. The rating firms project that company’s revenue will grow 3.28% compared to the previous financial year.

Revenue forecast for the current quarter as set by 6 analysts is 41.38M. Meanwhile, for the current quarter, a total of 6 analyst(s) estimate revenue growth to 42.79M.Earnings reports from the last fiscal year show that sales brought in 36.1M and 34.95M respectively in the corresponding quarters. In this case, analysts estimate current quarter sales to rise 14.62% before jumping 22.45% in the following quarter.

An assessment of the company’s 5-year growth patterns shows that annual earnings shrunk an estimated -19.48% for the past 5-year period. While 2024 is set for a 82.05% return in earnings, projections for the next 5 years are at 20.00% annually.

BLND Dividends

Blend Labs Inc has its next earnings report out in January. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.

Blend Labs Inc (NYSE:BLND)’s Major holders

Blend Labs Inc insiders hold 4.17% of total outstanding shares, with institutional holders owning 63.94% of the shares at 66.73% float percentage. In total, 63.94% institutions holds shares in the company, led by GENERAL ATLANTIC, L.P. As of 2024-06-30, the company held over 19.13 million shares (or 7.6246% of shares), all amounting to roughly $45.15 million.

The next major institution holding the largest number of shares is VANGUARD GROUP INC with 14.81 million shares, or about 5.9027% of shares outstanding. As of the market price on 2024-06-30, these shares were worth $34.96 million.